1. Park JW, Kim YR, Shin WS, Kang MW, Han KJ, Shim SI. Susceptibility tests of vancomycin-resistant enterococci. Korean J Infect Dis. 1992; 24:133–137.
2. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother. 2008; 52:2667–2672.
3. McKessar SJ, Berry AM, Bell JM, Turnidge JD, Paton JC. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother. 2000; 44:3224–3228.
4. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, et al. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother. 2010; 54:4643–4647.
5. Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, et al. D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 2011; 55:4606–4612.
6. Lee WG, Jernigan JA, Rasheed JK, Anderson GJ, Tenover FC. Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin-resistant Enterococcus faecium in a Korean hospital. J Clin Microbiol. 2001; 39:1165–1168.
7. Lee WG. Resistance mechanism and epidemiology of vancomycinresistant enterococci. Korean J Clin Microbiol. 2008; 11:71–77.
8. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol. 2002; 40:1963–1971.
9. Schlebusch S, Price GR, Gallagher RL, Horton-Szar V, Elbourne LD, Griffin P, et al. MALDI-TOF MS meets WGS in a VRE outbreak investigation. Eur J Clin Microbiol Infect Dis. 2017; 36:495–499.
10. Nowakiewicz A, Ziółkowska G, Zięba P, Gnat S, TroŚciańczyk A, Adaszek Ł. Characterization of multidrug resistant E. faecalis strains from pigs of local origin by ADSRRS-fingerprinting and MALDI-TOF MS; Evaluation of the compatibility of methods employed for multidrug resistance analysis. PLoS One. 2017; 12:e0171160.
11. McCarthy KL, Kidd TJ, Paterson DL. Molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non-outbreak setting. J Med Microbiol. 2017; 66:154–159.
12. Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, et al. Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis. 2007; 13:1024–1030.
13. Enright MC. Multilocus sequence typing. Trends Microbiol. 1999; 7:482–487.
14. Galloway-Peña JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE. Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J Infect Dis. 2009; 200:1566–1573.
15. Gordts B, Van Landuyt H, Ieven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol. 1995; 33:2842–2846.
16. Mato R, de Lencastre H, Roberts RB, Tomasz A. Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital. Microb Drug Resist. 1996; 2:309–317.
17. Oh JY, Her SH, Seo SY, Lee YC, Lee JC, Kim J, et al. Antimicrobial resistance and multilocus sequence typing of vancomycin-resistant Enterococcus faecium isolated from clinical specimens. J Bacteriol Virol. 2008; 38:19–27.
18. Lee WG, Lee SM, Kim YS. Molecular characterization of Enterococcus faecium isolated from hospitalized patients in Korea. Lett Appl Microbiol. 2006; 43:274–279.
19. Yang JX, Li T, Ning YZ, Shao DH, Liu J, Wang SQ, et al. Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: a hospital-based study in Beijing, China. Infect Genet Evol. 2015; 33:253–260.